Sands Capital Ventures LLC 13D and 13G filings for Acrivon Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 3:40 pm Sale |
2023-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Sands Capital Ventures LLC | 1,652,605 7.400% |
-1 (-0.00%) |
Filing |
| 2023-02-14 3:26 pm Purchase |
2022-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Sands Capital Ventures LLC | 1,652,606 7.900% |
1,652,606 (New Position) |
Filing |